Christoph Röllig Selected Research

Christoph Röllig Research Topics

Disease

56	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 07/2011
9	Multiple Myeloma 11/2023 - 08/2009
9	Neoplasms (Cancer) 10/2023 - 03/2006
8	Leukemia 11/2023 - 04/2012
6	Acute Promyelocytic Leukemia 12/2021 - 01/2010
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 12/2018
3	Pathologic Complete Response 04/2024 - 02/2012
3	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2016 - 06/2012
3	Disease Progression 08/2015 - 02/2015
2	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 10/2023
2	Residual Neoplasm 10/2020 - 07/2013
2	Infections 12/2015 - 06/2012
1	Body Weight (Weight, Body) 11/2023
1	Trisomy (Trisomies) 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 10/2020
1	Blast Crisis (Blast Phase) 01/2019
1	Pancreatitis 01/2019
1	Hypertriglyceridemia 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019
1	Fatigue 01/2017
1	Obesity 07/2016
1	Overweight 07/2016
1	Hemorrhage 12/2015
1	Exanthema (Rash) 12/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2015
1	Pain (Aches) 12/2015

Drug/Important Bio-Agent (IBA)

11	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2024 - 07/2011
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021 - 04/2015
4	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 06/2012
4	Arsenic Trioxide (Trisenox)FDA Link 12/2021 - 08/2009
3	Monoclonal AntibodiesIBA 11/2023 - 08/2015
3	venetoclaxIBA 10/2023 - 12/2022
3	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 09/2020 - 01/2011
3	NucleophosminIBA 10/2019 - 03/2016
2	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2024 - 06/2013
2	LigandsIBA 11/2023 - 03/2006
2	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2023 - 04/2015
2	AnthracyclinesIBA 09/2023 - 01/2023
2	midostaurinIBA 01/2023 - 01/2022
2	gilteritinibIBA 12/2022 - 01/2022
2	fms-Like Tyrosine Kinase 3IBA 01/2022 - 10/2020
2	RG7388IBA 01/2022 - 05/2020
2	Core Binding Factors (Core-Binding Factor)IBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016 - 08/2015
1	Cetrimonium (CTAB)IBA 03/2024
1	KIR ReceptorsIBA 11/2023
1	Genetic Markers (Genetic Marker)IBA 10/2023
1	alvocidib (flavopiridol)IBA 10/2023
1	tyramine-deoxysorbitolIBA 01/2023
1	fibrillarinIBA 01/2023
1	CohesinsIBA 01/2023
1	ChromatinIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023
1	Ribosomal RNAIBA 01/2023
1	glucarpidaseIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	BI 836858IBA 01/2022
1	isocitric acid (isocitrate)IBA 01/2022
1	selinexorIBA 12/2021
1	CPX-351IBA 10/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Decitabine FDA Link 01/2021
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2021
1	Gemtuzumab (Mylotarg)FDA Link 10/2020
1	multidrug resistance-associated protein 1IBA 09/2020
1	felzartamabIBA 05/2020
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2019
1	Histone Deacetylase InhibitorsIBA 10/2019
1	PanobinostatIBA 10/2019
1	Melphalan (Alkeran)FDA LinkGeneric 10/2019
1	Insulin (Novolin)FDA Link 01/2019
1	pegaspargase (Oncaspar)FDA Link 01/2019
1	Heparin (Liquaemin)FDA LinkGeneric 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Lysine (L-Lysine)FDA Link 12/2017
1	Clofarabine (Clolar)FDA Link 12/2017
1	MethyltransferasesIBA 12/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017
1	SteroidsIBA 02/2016
1	pomalidomideIBA 01/2016

Therapy/Procedure

17	Therapeutics 11/2023 - 01/2007
13	Cell Transplantation 12/2023 - 03/2004
12	Drug Therapy (Chemotherapy) 04/2024 - 01/2012
7	Hematopoietic Stem Cell Transplantation 10/2020 - 04/2012
4	Stem Cell Transplantation 01/2022 - 06/2012
2	Precision Medicine 10/2023 - 01/2023
2	Immunotherapy 01/2011 - 03/2006
1	Remission Induction 04/2024
1	Blood Component Removal (Apheresis) 11/2023
1	Consolidation Chemotherapy 01/2023
1	Radioimmunotherapy 01/2020
1	Intravenous Infusions 01/2019